MicroRNA-140 regulates cell growth and invasion in pancreatic duct adenocarcinoma by targeting iASPP

Acta Biochimica et Biophysica Sinica

Volumn 48, Issue 2, 2015, Pages 174-181

  Liang, Shuai ^a   Gong, Xuejun ^a   Zhang, Gewen ^a   Huang, Gengwen ^a   Lu, Yebin ^a   Li, Yixiong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

cell invasion; cell proliferation; iASPP; miR 140; pancreatic duct adenocarcinoma

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN140 MICRORNA, HUMAN; PPP1R13L PROTEIN, HUMAN; REPRESSOR PROTEIN; RNA; SIGNAL PEPTIDE;

ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84960350499     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmv127     Document Type: Article

References (36)

1. Kozak G, Blanco FF, Brody JR. Novel targets in pancreatic cancer research. Semin Oncol 2015, 42: 177-187.
2. KongkamP, Benjasupattananun P, Taytawat P, Navicharoen P, Sriuranpong V, Vajragupta L, Klaikaew N, et al. Pancreatic cancer in an Asian population. Endosc Ultrasound 2015, 4: 56-62.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297.
4. Lan H, Lu H, Wang X, Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int 2015, 2015: 125094.
5. Lai XL, Huang YH, Li YS, Li GN, Wang LP, Sun R, Ma YS, et al. Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer. Clin Transl Oncol 2015, 17: 398-408.
6. Pavlakis E, Papaconstantinou I, Gazouli M, Theodosopoulos T, Karamanolis G, Genatas K, Ladas SD. MicroRNA gene polymorphisms in pancreatic cancer. Pancreatology 2013, 13: 273-278.
7. Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, Fujita H, Nakata K, et al. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 2010, 9: 169.
8. Li Y, VandenBoom TG II, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells. Cancer Res 2010, 70: 5703.
9. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, et al. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol 2009, 16: 2339-2350.
10. Li Y, VandenBoom TG II, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 2009, 69: 6704-6712.
11. Huang F, Tang J, Zhuang X, Zhuang Y, Cheng W, Chen W, Yao H, et al. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. PLoS One 2014, 9: e87897.
12. Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H, WangW, et al. miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. J Exp Clin Cancer Res 2014, 33: 54.
13. Laurila EM, Sandstrom S, Rantanen LM, Autio R, Kallioniemi A. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells. Genes Chromosomes Cancer 2012, 51: 557-568.
14. Li Q, Yao Y, Eades G, Liu Z, Zhang Y, Zhou Q. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene 2014, 33: 2589-2600.
15. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009, 28: 4065-4074.
16. Yang H, Fang F, Chang R, Yang L. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 2013, 58: 205-217.
17. Hwang S, Park SK, Lee HY, Kim SW, Lee JS, Choi EK, You D, et al. miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett 2014, 588: 2957-2963.
18. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6: 259-269.
19. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2007, 96 (Suppl): R40-R44.
20. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120: 15-20.
21. NotariM, Hu Y, Koch S, Lu M, Ratnayaka I, Zhong S, Baer C, et al. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification. Proc Natl Acad Sci USA 2011, 108: 16645-16650.
22. Danilov AV, Neupane D, Nagaraja AS, Feofanova EV, Humphries LA, DiRenzo J, Korc M. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance. PLoS One 2011, 6: e26815.
23. Guo JQ, Zheng QH, Chen H, Chen L, Xu JB, Chen MY, Lu D, et al. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VEcadherin/EphA2/MMP9/MMP2 expression. Int J Oncol 2014, 45: 1065-1072.
24. Profumo V, Doldi V, Gandellini P, Zaffaroni N. Targeting microRNAs to withstand cancer metastasis. Methods Mol Biol 2015, 1218: 415-437.
25. Chen J, Sun D, Chu H, Gong Z, Zhang C, Gong B, Li Y, et al. Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction. Oncol Rep 2015, 33: 2963-2971.
26. Chen J, Xie F, Zhang L, Jiang WG. iASPP is over-expressed in human nonsmall cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer 2010, 10: 694.
27. Gillotin S. iASPP, a potential drug target in cancer therapy. Leuk Res 2009, 33: 1175-1177.
28. Liu T, Li L, Yang W, Jia H, Xu M, Bi J, Li Z, et al. iASPP is important for bladder cancer cell proliferation. Oncol Res 2011, 19: 125-130.
29. Jia Y, Peng L, Rao Q, Xing H, Huai L, Yu P, Chen Y, et al. Oncogene iASPP enhances self-renewal of hematopoietic stem cells and facilitates their resistance to chemotherapy and irradiation. FASEB J 2014, 28: 2816-2827.
30. Zhang X, Diao S, Rao Q, Xing H, Liu H, Liao X, Wang M, et al. Identification of a novel isoform of iASPP and its interaction with p53. J Mol Biol 2007, 368: 1162-1171.
31. Deyoung MP, Ellisen LW. p63 and p73 in human cancer: defining the network. Oncogene 2007, 26: 5169-5183.
32. Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. J Clin Invest 2007, 117: 1370-1380.
33. Rocco JW, Leong CO, Kuperwasser N, DeYoungMP, Ellisen LW. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006, 9: 45-56.
34. Zhai LL, Cai CY, Wu Y, Tang ZG. Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma. Int J Clin Exp Pathol 2015, 8: 682-691.
35. Kilian M, Gregor JI, Heukamp I, Hanel M, Ahlgrimm M, Schimke I, Kristiansen G, et al. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 andMMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer. Prostaglandins Leukot Essent Fatty Acids 2006, 75: 429-434.
36. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141: 52-67.